Corporate ActionAug 10, 2026, 04:54 PM
ClearOne Files S-1 for $10M-$15M Unit Offering
AI Summary
ClearOne, Inc. filed an S-1 registration statement for a public offering of Units, each consisting of one common stock share and one warrant, aiming to raise between $10 million and $15 million. This capital raise is intended to support the company's strategic transformation, including its pending merger with Cortigent, Inc. Cortigent is a pre-revenue medical device company focused on developing neurostimulation systems for artificial vision (Orion) and stroke recovery, both of which are high-potential, high-risk Class III devices requiring significant future funding and regulatory approvals.
Key Highlights
- ClearOne filed an S-1 registration statement for a public offering of Units to raise capital.
- The offering includes a minimum of 2,857,142 Units and a maximum of 4,285,714 Units at $3.50 each.
- The company aims to raise between $10,000,000 and $15,000,000 in gross proceeds from the offering.
- ClearOne is undergoing a merger with Cortigent, Inc., a medical device company focused on neurostimulation.
- Cortigent is developing the Orion Visual Cortical Prosthesis System for artificial vision, with a potential $4 billion US market.
- Cortigent is also developing a Stroke Recovery System, targeting a potential $6 billion US market.
- Cortigent is a pre-revenue company with a history of operating losses, requiring substantial additional capital.
- ClearOne disposed of substantially all its legacy operating assets to Biamp Systems, LLC in October 2025.
Price Impact
More from CLRO